化工社化工社 化学情報印刷レポート · 研究参考用
Ciprofloxacin → 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Ciprofloxacin | HCID 2764 | — |
| 反応物 | Potassium Bicarbonate | HCID 516893 | — |
| 反応物 | 4-(Bromomethyl)-5-methyl-1,3-dioxol-2-one | HCID 10774141 | — |
| 溶媒 | Dimethylformamide | HCID 6228 | — |
| 生成物 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid | HCID 13673272 | — |
反応手順
1.15 g (3.5 mmoles) of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid are stirred in 20 ml of dimethylformamide with 0.85 g (4.4 mmoles) of 4-bromomethyl-5-methyl-1,3-dioxol-2-one and 0.42 g (4.2 mmoles) of powdered potassium bicarbonate for 3 days, while cooling with ice. The mixture is concentrated in vacuo, the residue is stirred with 20 ml of water, the resulting greasy product is dissolved in methanol and the solution is filtered. The filtrate is left to stand at room temperature for 2 days and the colorless crystals which have precipitated are isolated.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US04703047 |
| 出典データセット | uspto-grants-1987_10 |
| ORD ID | ord-a73071cede0544c8b4b53d87ab259d7d |
| 出典メモ | uspto-grants-1987_10 |